ESR2 and Familial adenomatous polyposis: Overall, these studies show that phytoestrogens and ER-β agonists in general can not only play a protective role in FAP, but also that they are very selective for this receptor subtype and therefore their use does not lead to the occurrence of any relevant side effects.